Objectives: To (1) assess the current extent of medication therapy management (MTM) provision in NYC; (2) investigate New York City pharmacists' attitudes, efforts, interest, and challenges in providing MTM; and 3) examine factors influencing pharmacist interest in providing MTM. Methods: A cross-sectional design was utilized to survey New York City pharmacists attending a continuing education program. The survey questionnaire contained items pertaining to the extent of MTM currently provided by the pharmacists, attitudes, efforts, and interest in providing MTM and challenges to provision of MTM. Results: A total of 93 out of 123 attendees (73.81%) completed the survey. Pharmacists provided an average of 1.65 (±0.36) MTM services as defined by the APhA and NACDS framework. Pharmacists had slightly positive attitudes toward provision of MTM and were very interested in providing some MTM services. There was a positive correlation between pharmacist attitude toward MTM and interest in providing MTM (r = .31, P = .016). Of all the 6 challenges to provision of MTM listed in the survey, respondents indicated that additional time to be spent with patients and additional pharmacists would be the most difficult to overcome. Conclusions: This study serves as an assessment of the needs of New York City pharmacists with regard to provision of MTM services.
McGivneyMSMeyerSMDuncan-HewittW. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc. 2007;47(5):620–628.
2.
PartM. Ready or not, here comes medication therapy management!. J Am Pharm Assoc. 2005;45(6):646–652.
3.
BlumlBM. Definition of medication therapy management: development of profession wide consensus. J Am Pharm Assoc. 2005;45(5):566–572.
ThompsonCA. National billing codes announced for pharmacists' clinical services. Am J Health Syst Pharm. 2005;62(16):1640,2.
6.
TouchetteDRBurnsALBoughMA. Survey of medication therapy management programs under Medicare part D. J Am Pharm Assoc. 2006;46(6):683–691.
7.
SchommerJCPlanasLGJohnsonKA. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007. J Am Pharm Assoc. 2008;48(4):478–486.
8.
MoczygembaLRBarnerJCRobersonK. Texas pharmacists' opinions about and plans for provision of medication therapy management services. J Am Pharm Assoc. 2008;48(1):38–45.
9.
BlakeKBMadhavanSSScottVG. Medication therapy management services in West Virginia: pharmacists' perceptions of educational and training needs. Res Social Adm Pharm. 2009;5(2):182–188.
RaischDW. Barriers to providing cognitive services. Am Pharm. 1993;NS33(12):54–58.
12.
BarnesJMRiedlingerJEMcCloskeyWW. Barriers to compliance with OBRA'90 regulations in community pharmacies. Ann Pharmacother. 1996;30(10):1101–1105.
13.
VenkataramanKMadhavanSBoneP. Barriers and facilitators to pharmaceutical care in rural community practice. J Soc Admin Pharm. 1997;14(4):208–219.
14.
LounsberyJLGreenCGBennettMS. Evaluation of pharmacists' barriers to the implementation of medication therapy management services. J Am Pharm Assoc. 2009;49(1):51–58.
15.
MasonHL. Using attitudes and subjective norms to predict pharmacist counseling behaviors. Patient Couns Health Educ. 1983;4(4):190–196.
16.
SchommerJC. In: The roles of pharmacists, patients, and contextual cues in pharmacist-patient communication.1992;Madison: University of Wisconsin,
17.
ColemanCL. Examining influences of pharmacists communication with consumers about antibiotics. Health Commun. 2003;15(1):79–99.
18.
CarrollNVGagnonJP. The relationship between patient variables and frequency of pharmacist counseling. Ann Pharmacother. 1983;17(9):648.
19.
HerbertKEUrmieJMNewlandBA. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Res Social Adm Pharm. 2006;2(3):299–314.
KnappKKQuistRMWaltonSM. Update on the pharmacist shortage: national and state data through 2003. Am J Health Syst Pharm. 2005;62(5):492.
22.
GershonSKCulticeJMKnappKK. How many pharmacists are in our future? The Bureau of Health Professions projects supply to 2020. J Manag Care Pharm. 2000;6(6):474–482.
